Menu Search
Equities

Central Proteina Prima Tbk PT

4PT:STU

Central Proteina Prima Tbk PT

Actions
  • Price (EUR)0.0005
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-75.00%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Central Proteina Prima Tbk is an Indonesia-based integrated aquaculture shrimp and foods producer company. The Company's business includes feed, food, and farm and hatchery. Its feed business includes shrimp feed, fish feed, pet food, and aquatic animal healthcare solutions. Its products are sold in domestic and international markets. It supplies shrimp products to international markets, such as India, Vietnam, China, Japan, United States of America, Canada, United Kingdom, Belgium, France, Netherland, Germany and New Zealand. The Company's farm and hatchery business includes fish hatchery and shrimp hatchery. Its shrimp feed products include IRAWAN 681 V, IRAWAN 682 V, IRAWAN 683 PV, IRAWAN 683 SP, 581, 6003 and 6004, 999, 583 - SP and 583. Its shrimp feed products brands include Irawan, Bintang, Novo and Marine. Its aquatic animal healthcare solutions provide products, such as probiotics, feed additives, disinfectants and other products supporting shrimp and fish aquaculture.

  • Revenue in IDR (TTM)9.18tn
  • Net income in IDR385.17bn
  • Incorporated1981
  • Employees1.77k
  • Location
    Central Proteina Prima Tbk PTPuri Matari 2 BuildingJl. HR Rasuna Said Kav H1- 2, SetiabudiJAKARTA SELATAN 12920IndonesiaIDN
  • Phone+62 2 150191788
  • Fax+62 2 150191808
  • Websitehttps://www.cpp.co.id/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.